Skip to content
HCC Buddy home

FY2027 ICD-10-CM reference

D61.82: Myelophthisis

By the HCC Buddy Coding Team

The official ICD-10-CM descriptor is Myelophthisis. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.

Billable code. Verified against the official FY2027 order file.

CMS-HCC V28

  • HCC 109: Acquired Hemolytic, Aplastic, and Sideroblastic Anemias · RAF 1.144, Community Non-Dual Aged (CNA)

Payment year 2027, 2026 dates of service. HCC from the CMS 2027 Initial ICD-10-CM Mappings; RAF from the CMS-HCC V28 relative factors. For 2027 dates of service, CMS has not yet published the payment year 2028 mappings.

CMS-HCC V24

Not used for payment year 2027 Medicare Advantage payment

ESRD

Source verification pending

PACE

Source verification pending

RxHCC

Source verification pending

HHS-HCC

Source verification pending

FY2027 Tabular instructions

Instructions below include applicable chapter, section and parent-code notes. Each note identifies where it appears in the official source.

Excludes2

autoimmune disease (systemic) NOS (M35.9)

Source: D50-D89 (chapter, inherited).

Excludes2

certain conditions originating in the perinatal period (P00-P96)

Source: D50-D89 (chapter, inherited).

Excludes2

complications of pregnancy, childbirth and the puerperium (O00-O9A)

Source: D50-D89 (chapter, inherited).

Excludes2

congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)

Source: D50-D89 (chapter, inherited).

Excludes2

endocrine, nutritional and metabolic diseases (E00-E88)

Source: D50-D89 (chapter, inherited).

Excludes2

human immunodeficiency virus [HIV] disease (B20)

Source: D50-D89 (chapter, inherited).

Excludes2

injury, poisoning and certain other consequences of external causes (S00-T88)

Source: D50-D89 (chapter, inherited).

Excludes2

neoplasms (C00-D49)

Source: D50-D89 (chapter, inherited).

Excludes2

symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

Source: D50-D89 (chapter, inherited).

Excludes2

neutropenia (D70.-)

Source: D61 (category, inherited).

Instructional note

Leukoerythroblastic anemia

Source: D61.82 (self, direct).

Instructional note

Myelophthisic anemia

Source: D61.82 (self, direct).

Instructional note

Panmyelophthisis

Source: D61.82 (self, direct).

Code also

the underlying disorder, such as:

Source: D61.82 (self, direct).

Code also

malignant neoplasm of breast (C50.-)

Source: D61.82 (self, direct).

Code also

tuberculosis (A15.-)

Source: D61.82 (self, direct).

Excludes1

idiopathic myelofibrosis (D47.1)

Source: D61.82 (self, direct).

Excludes1

myelofibrosis NOS (D75.81)

Source: D61.82 (self, direct).

Excludes1

myelofibrosis with myeloid metaplasia (D47.4)

Source: D61.82 (self, direct).

Excludes1

primary myelofibrosis (D47.1)

Source: D61.82 (self, direct).

Excludes1

secondary myelofibrosis (D75.81)

Source: D61.82 (self, direct).

Source: CMS FY2027 Tabular List and Alphabetic Index.

Open Tabular instructions and code details

Compare the FY2027 additions, removals and billable-status changes

What does D61.82 mean in FY2027?

The official ICD-10-CM descriptor is Myelophthisis. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.

Is D61.82 billable in FY2027?

The FY2027 order file marks D61.82 as billable. Check the complete Tabular instructions and documentation before assigning it.

Does D61.82 map to an HCC?

In the CMS 2027 Initial ICD-10-CM Mappings (payment year 2027, 2026 dates of service), D61.82 maps to CMS-HCC V28 HCC 109 (Acquired Hemolytic, Aplastic, and Sideroblastic Anemias). For 2027 dates of service, CMS has not yet published the payment year 2028 mappings. ESRD, RxHCC, PACE and HHS-HCC mappings are still pending verification for FY2027.

Source: CMS FY2027 ICD-10-CM order file. Read the FY2027 Official Guidelines.

Review the FY2026 April edition